{"id":15399,"date":"2026-06-03T18:47:00","date_gmt":"2026-06-03T16:47:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=26e5bccc559ba86bfe1f6ab546cd776f"},"modified":"2026-06-03T18:47:00","modified_gmt":"2026-06-03T16:47:00","slug":"beta-bionics-investors-suffer-significant-losses-after-company-reports-slower-new-patient-start-growth-contact-johnson-fistel","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=15399","title":{"rendered":"Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel"},"content":{"rendered":"

SAN DIEGO--(BUSINESS WIRE)--$bbnx<\/a> #BBNX<\/a>--Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors\u2019 losses and whether they may be recovered under federal securities laws.<\/p><\/a><\/a>

What if I purchased Beta Bionics securities?<\/b><\/p>

If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation<\/a>.<\/p>

Or for more information, contact Jim Baker at jimb@johnsonfistel.com<\/a> or (619) 814-4471.<\/p>

There is no cost or obligation to you.<\/p>

Background of the Investigation<\/b><\/p>

On January 8, 2026, Beta Bionics announced preliminary, unaudited financial results and key operating metrics for the fourth quarter of 2025. The Company reported that new patient starts were expected to be at least 5,581 for the quarter, representing year-over-year growth of at least 36%. Despite the reported growth, the results were below reported analyst expectations and reflected a significant deceleration from the prior quarter, when Beta Bionics reported 68% year-over-year growth in new patient starts.<\/p>

Investors reacted swiftly to the disclosure. On January 9, 2026, Beta Bionics\u2019 stock price fell more than 35%, erasing substantial shareholder value and reflecting investor concern that the Company\u2019s growth trajectory had slowed relative to expectations.<\/p>

In light of this disclosure, Johnson Fistel is investigating whether Beta Bionics complied with federal securities laws. If you suffered losses, contact Johnson Fistel for more information.<\/p>

About Johnson Fistel, PLLP | Securities Fraud & Investor Rights<\/b><\/p>

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder class actions and derivative lawsuits. Johnson Fistel has been recognized as one of the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. In 2024, the firm recovered approximately $90,725,000 for investors.<\/p>

Attorney advertising.Past results do not guarantee future outcomes.Services may be performed by attorneys in any of our offices.Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.<\/p> Contacts<\/b>

Johnson Fistel, PLLP501 W. Broadway, Suite 800San Diego, CA 92101James Baker, Investor Relations \u2013 or \u2013 Frank J. Johnson, Esq.(619) 814-4471 | jimb@johnsonfistel.com<\/a> | fjohnson@johnsonfistel.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–$bbnx #BBNX–Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors\u2019 losses and whether t…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15399","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15399"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15399\/revisions"}],"predecessor-version":[{"id":15400,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15399\/revisions\/15400"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}